Abstract
Guanine nucleotide regulatory proteins (G proteins) play a key role in the regulation of various signal transduction systems including adenylyl cyclase–cAMP and phospholipase C (PLC)–phosphatidylinositol turnover (PI). These proteins are implicated in the modulation of a variety of physiological functions such as platelet functions, including platelet aggregation, secretion, and clot formation, and cardiovascular functions, including arterial tone and reactivity. Several abnormalities in adenylyl cyclase activity, cAMP levels, G proteins, and PLC/PKC have shown to be responsible for the altered cardiac performance and vascular functions observed in cardiovascular disease states. The enhanced or unaltered levels of inhibitory G proteins (Giα-2 and Giα-3) and mRNA have been reported in different models of hypertension, whereas Gsα levels were shown to be unaltered. These changes in G protein were associated with functions. The enhanced levels of Giα proteins precede the development of blood pressure and suggest that overexpression of Gi proteins may be one of the contributing factors for the pathogenesis of hypertension. The augmented levels of Giα proteins and associated adenylyl cyclase signaling in hypertension were shown to be attributed to the enhanced levels of vasoactive peptides. In addition, enhanced oxidative stress in hypertension may also be responsible for the enhanced expression of Giα proteins observed in hypertension. The augmented levels of Giα(alpha) proteins and associated adenylyl cyclase signaling in hypertension appear to be attributed to the enhanced levels of vasoactive peptides, which by increasing oxidative stress and transactivating growth factor receptors enhance MAP kinase activity that contributes to the enhanced expression of Giα proteins observed in hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rodbell M, Krans HM, Pohl SL, et al. The glucagon-sensitive adenylyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon. J Biol Chem. 1971;246:1872–6.
Cockcroft S, Gomperts BD. Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature. 1985;314:534–6.
Litosch I, Wallis C, Fain JN. 5-Hydroxytryptamine stimulates inositol phosphate production in a cell-free system from blowfly salivary glands. Evidence for a role of GTP in coupling receptor activation to phosphoinositide breakdown. J Biol Chem. 1985;260:5464–71.
Breitwieser GE, Szabo G. Uncoupling of cardiac muscarinic and beta-adrenergic receptors from ion channels by a guanine nucleotide analogue. Nature. 1985;317:538–40.
Pfaffinger PJ, Martin JM, Hunter DD, et al. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature. 1985;317:536–8.
Gilman AG. G proteins and dual control of adenylate cyclase. Cell. 1984;36:577–9.
Bray P, Carter A, Simons C, et al. Human cDNA clones for four species of G alpha s signal transduction protein. Proc Natl Acad Sci USA. 1986;83:8893–7.
Robishaw JD, Smigel MD, Gilman AG. Molecular basis for two forms of the G protein that stimulates adenylate cyclase. J Biol Chem. 1986;261:9587–90.
Murakami T, Yasuda H. Rat heart cell membranes contain three substrates for cholera toxin-catalyzed ADP-ribosylation and a single substrate for pertussis toxin-catalyzed ADP-ribosylation. Biochem Biophys Res Commun. 1986;138:1355–61.
Stryer L, Bourne HR. G proteins: a family of signal transducers. Annu Rev Cell Biol. 1986;2:391–419.
Spiegel AM. Signal transduction by guanine nucleotide binding proteins. Mol Cell Endocrinol. 1987;49:1–16.
Wankerl M, Schwartz K. Calcium transport proteins in the nonfailing and failing heart: gene expression and function. J Mol Med. 1995;73:487–96.
Yatani A, Brown AM. Rapid beta-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway. Science. 1989;245:71–4.
Itoh H, Kozasa T, Nagata S, et al. Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. Proc Natl Acad Sci USA. 1986;83:3776–80.
Jones DT, Reed RR. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J Biol Chem. 1987;262:14241–9.
Itoh H, Toyama R, Kozasa T, et al. Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs. J Biol Chem. 1988;263:6656–64.
Wong YH, Conklin BR, Bourne HR. Gz-mediated hormonal inhibition of cyclic AMP accumulation. Science. 1992;255:339–42.
Kirsch GE, Yatani A, Codina J, et al. Alpha-subunit of Gk activates atrial K+ channels of chick, rat, and guinea pig. Am J Physiol Heart Circ Physiol. 1988;254:H1200–5.
Simon MI, Strathmann MP, Gautam N. Diversity of G proteins in signal transduction. Science. 1991;252:802–8.
Tang WJ, Gilman AG. Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science. 1991;254:1500–3.
Wickman KD, Iniguez-Lluhl JA, Davenport PA, et al. Recombinant G-protein beta gamma-subunits activate the muscarinic-gated atrial potassium channel. Nature. 1994;368:255–7.
Wedegaertner PB, Wilson PT, Bourne HR. Lipid modifications of trimeric G proteins. J Biol Chem. 1995;270:503–6.
Taussig R, Iniguez-Lluhi JA, Gilman AG. Inhibition of adenylyl cyclase by Gi alpha. Science. 1993;261:218–21.
Anand-Srivastava MB, Picard S, Thibault C. Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi alpha) in spontaneously hypertensive rats. Am J Hypertens. 1991;4:840–3.
Anand-Srivastava MB. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition. Biochem J. 1992;288:79–85.
Thibault C, Anand-Srivastava MB. Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett. 1992;313:160–4.
Anand-Srivastava MB. Platelets from spontaneously hypertensive rats exhibit decreased expression of inhibitory guanine nucleotide regulatory protein. Relation with adenylyl cyclase activity. Circ Res. 1993;73:1032–9.
Anand-Srivastava MB, de Champlain J, Thibault C. DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am J Hypertens. 1993;6:72–5.
Bohm M, Gierschik P, Knorr A, et al. Cardiac adenylyl cyclase, beta-adrenergic receptors, and G proteins in salt-sensitive hypertension. Hypertension. 1993;22:715–27.
Li P, Zou AP, al-Kayed NJ, et al. Guanine nucleotide-binding proteins in aortic smooth muscle from hypertensive rats. Hypertension. 1994;23:914–8.
Bohm M, Gierschik P, Knorr A, et al. Desensitization of adenylate cyclase and increase of Gi alpha in cardiac hypertrophy due to acquired hypertension. Hypertension. 1992;20:103–12.
Di Fusco F, Anand-Srivastava MB. Nitric oxide synthase inhibition by N(omega)-nitro-L-arginine methyl ester modulates G-protein expression and adenylyl cyclase activity in rat heart. Am J Hypertens. 1997;10:471–5.
Di Fusco F, Anand-Srivastava MB. Enhanced expression of Gi proteins in non-hypertrophic hearts from rats with hypertension-induced by L-NAME treatment. J Hypertens. 2000;18:1081–90.
Ge C, Garcia R, Anand-Srivastava MB. Altered expression of Gi-protein and adenylyl cyclase activity in hearts from one kidney one clip hypertensive rats: effect of captopril. J Hypertens. 1999;17:1617–26.
Ge C, Garcia R, Anand-Srivastava MB. Enhanced expression of Gialpha protein and adenylyl cyclase signaling in aortas from 1 kidney 1 clip hypertensive rats. Can J Physiol Pharmacol. 2006;84:739–46.
Clark CJ, Milligan G, Connell JM. Guanine nucleotide regulatory protein alterations in the Milan hypertensive rat strain. J Hypertens. 1993;11:1161–9.
Michel MC, Farke W, Erdbrugger W, et al. Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. II. Renal G proteins in male and female rats. Hypertension. 1994;23:653–8.
Kanagy NL, Webb RC. Increased responsiveness and decreased expression of G proteins in deoxycorticosterone hypertension. Hypertension. 1996;27:740–5.
Marcil J, Schiffrin EL, Anand-Srivastava MB. Aberrant adenylyl cyclase/cAMP signal transduction and G protein levels in platelets from hypertensive patients improve with antihypertensive drug therapy. Hypertension. 1996;28:83–90.
McLellan AR, Milligan G, Houslay MD, et al. G-proteins in essential hypertension: a study of human platelet plasma membranes. J Hypertens. 1993;11:543–9.
Marcil J, Anand-Srivastava MB. Lymphocytes from spontaneously hypertensive rats exhibit enhanced adenylyl cyclase-Gi protein signaling. Cardiovasc Res. 2001;49:234–43.
Feldman RD, Tan CM, Chorazyczewski J. G protein alterations in hypertension and aging. Hypertension. 1995;26:725–32.
Hamet P, Franks DJ, Adnot S, et al. Cyclic nucleotides in hypertension. Adv Cyclic Nucleotide Res. 1980;12:11–23.
Anand-Srivastava MB. Altered responsiveness of adenylate cyclase to adenosine and other agents in the myocardial sarcolemma and aorta of spontaneously-hypertensive rats. Biochem Pharmacol. 1988;37:3017–22.
Limas C, Limas CJ. Reduced number of beta-adrenergic receptors in the myocardium of spontaneously hypertensive rats. Biochem Biophys Res Commun. 1978;83:710–4.
Woodcock EA, Funder JW, Johnston CI. Decreased cardiac beta-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res. 1979;45:560–5.
Bhalla RC, Sharma RV, Ramanathan S. Ontogenetic development of isoproterenol subsensitivity of myocardial adenylate cyclase and beta-adrenergic receptors in spontaneously hypertensive rats. Biochim Biophys Acta. 1980;632:497–506.
Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest. 1989;84:1849–56.
Marcil J, Thibault C, Anand-Srivastava MB. Enhanced expression of Gi-protein precedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol. 1997;29:1009–22.
Marcil J, de Champlain J, Anand-Srivastava MB. Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase. Cardiovasc Res. 1998;39:492–505.
Li Y, Anand-Srivastava MB. Inactivation of enhanced expression of G(i) proteins by pertussis toxin attenuates the development of high blood pressure in spontaneously hypertensive rats. Circ Res. 2002;91:247–54.
Trinder D, Phillips PA, Risvanis J, et al. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension. Hypertension. 1992;20:569–74.
Wahlander H, Wickman A, Isgaard J, et al. Interaction between the renin-angiotensin system and insulin-like growth factor I in aorto-caval fistula-induced cardiac hypertrophy in rats. Acta Physiol Scand. 1999;165:143–54.
Kagiyama S, Eguchi S, Frank GD, et al. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation. 2002;106:909–12.
Kagiyama S, Qian K, Kagiyama T, et al. Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy. Hypertension. 2003;41:824–9.
Iglarz M, Schiffrin EL. Role of endothelin-1 in hypertension. Curr Hypertens Rep. 2003;5:144–8.
Kirchengast M, Witte K, Stolpe K, et al. Effects of chronic endothelin ET(A) receptor blockade on blood pressure and vascular formation of cyclic guanosine-3′,5′-monophosphate in spontaneously hypertensive rats. Arzneimittelforschung. 2005;55:498–504.
Schermuly RT, Dony E, Ghofrani HA, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest. 2005;115:2811–21.
Morishita R, Higaki J, Miyazaki M, et al. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension. 1992;19(2 Suppl):II62–7.
Jesmin S, Zaedi S, Maeda S, et al. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage. Exp Biol Med (Maywood). 2006;231:919–24.
Pandey SK, Anand-Srivastava MB. Modulation of G-protein expression by the angiotensin converting enzyme inhibitor captopril in hearts from spontaneously hypertensive rats. Relationship with adenylyl cyclase. Am J Hypertens. 1996;9:833–7.
Hashim S, Anand-Srivastava MB. Losartan-induced attenuation of blood pressure in L-NAME hypertensive rats is associated with reversal of the enhanced expression of Gi alpha proteins. J Hypertens. 2004;22:181–90.
Sims C, Ashby K, Douglas JG. Angiotensin II-induced changes in guanine nucleotide binding and regulatory proteins. Hypertension. 1992;19:146–52.
Bohm M, Kirchmayr R, Erdmann E. Myocardial Gi alpha-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock. Cardiovasc Res. 1995;30:611–8.
Gomez Sandoval YH, Anand-Srivastava MB. Enhanced levels of endogenous endothelin-1 contribute to the over expression of Gialpha protein in vascular smooth muscle cells from SHR: role of growth factor receptor activation. Cell Signal. 2011;23:354–62.
Jankov RP, Kantores C, Belcastro R, et al. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol. 2005;288:L1162–70.
Daub H, Weiss FU, Wallasch C, et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996;379:557–60.
Sumitomo M, Milowsky MI, Shen R, et al. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. Cancer Res. 2001;61:3294–8.
Li Y, Levesque LO, Anand-Srivastava MB. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Am J Physiol Heart Circ Physiol. 2010;299:H1959–67.
Ge C, Anand-Srivastava MB. Involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in AII-mediated enhanced expression of Gi proteins in vascular smooth muscle cells. Biochem Biophys Res Commun. 1998;251:570–5.
Li Y, Lappas G, Anand-Srivastava MB. Role of oxidative stress in angiotensin II-induced enhanced expression of Gi(alpha) proteins and adenylyl cyclase signaling in A10 vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2007;292:H1922–30.
Lappas G, Daou GB, Anand-Srivastava MB. Oxidative stress contributes to the enhanced expression of Gialpha proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens. 2005;23:2251–61.
Bassil M, Anand-Srivastava MB. Nitric oxide modulates Gi-protein expression and adenylyl cyclase signaling in vascular smooth muscle cells. Free Radic Biol Med. 2006;41:1162–73.
Bassil M, Anand-Srivastava MB. Cyclic GMP modulates the expression of Gi protein and adenylyl cyclase signaling in vascular smooth muscle cells. Cell Biochem Biophys. 2007;47:99–108.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Anand-Srivastava, M.B. (2011). Modulation of Gi Protein Expression in Hypertension: Molecular Mechanisms. In: Dhalla, N., Nagano, M., Ostadal, B. (eds) Molecular Defects in Cardiovascular Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7130-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7130-2_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7129-6
Online ISBN: 978-1-4419-7130-2
eBook Packages: MedicineMedicine (R0)